112 related articles for article (PubMed ID: 7648819)
41. Enzymatic, metabolic and secretory perturbations in pancreatic islets of thyroidectomized rats.
Sener A; Malaisse-Lagae F; Gervy-Decoster C; Malaisse WJ
Cell Biochem Funct; 1993 Jun; 11(2):145-51. PubMed ID: 8324884
[TBL] [Abstract][Full Text] [Related]
42. Characterization of succinate dehydrogenase and alpha-glycerophosphate dehydrogenase in pancreatic islets.
Lenzen S; Panten U
Biochem Med; 1983 Dec; 30(3):349-56. PubMed ID: 6360162
[TBL] [Abstract][Full Text] [Related]
43. Mouse lacking NAD+-linked glycerol phosphate dehydrogenase has normal pancreatic beta cell function but abnormal metabolite pattern in skeletal muscle.
MacDonald MJ; Marshall LK
Arch Biochem Biophys; 2000 Dec; 384(1):143-53. PubMed ID: 11147825
[TBL] [Abstract][Full Text] [Related]
44. Impairment of glycerol phosphate shuttle in islets from rats with diabetes induced by neonatal streptozocin.
Giroix MH; Rasschaert J; Bailbe D; Leclercq-Meyer V; Sener A; Portha B; Malaisse WJ
Diabetes; 1991 Feb; 40(2):227-32. PubMed ID: 1825072
[TBL] [Abstract][Full Text] [Related]
45. Deficiency of pyruvate dehydrogenase activity in pancreatic islets of diabetic GK rats.
Zhou YP; Ostenson CG; Ling ZC; Grill V
Endocrinology; 1995 Aug; 136(8):3546-51. PubMed ID: 7628391
[TBL] [Abstract][Full Text] [Related]
46. Expression of CD38 gene, but not of mitochondrial glycerol-3-phosphate dehydrogenase gene, is impaired in pancreatic islets of GK rats.
Matsuoka T; Kajimoto Y; Watada H; Umayahara Y; Kubota M; Kawamori R; Yamasaki Y; Kamada T
Biochem Biophys Res Commun; 1995 Sep; 214(1):239-46. PubMed ID: 7669044
[TBL] [Abstract][Full Text] [Related]
47. Identification and functional analysis of mutations in FAD-binding domain of mitochondrial glycerophosphate dehydrogenase in caucasian patients with type 2 diabetes mellitus.
Gudayol M; Vidal J; Usac EF; Morales A; Fabregat ME; Fernández-Checa JC; Novials A; Gomis R
Endocrine; 2001 Oct; 16(1):39-42. PubMed ID: 11822825
[TBL] [Abstract][Full Text] [Related]
48. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.
Madiraju AK; Erion DM; Rahimi Y; Zhang XM; Braddock DT; Albright RA; Prigaro BJ; Wood JL; Bhanot S; MacDonald MJ; Jurczak MJ; Camporez JP; Lee HY; Cline GW; Samuel VT; Kibbey RG; Shulman GI
Nature; 2014 Jun; 510(7506):542-6. PubMed ID: 24847880
[TBL] [Abstract][Full Text] [Related]
49. Evidence of an age-related decline in mitochondrial glycerophosphate dehydrogenase activity of isolated rat islets.
Azhar S; Ho H; Reaven EP; Reaven GM
Metabolism; 1983 Nov; 32(11):1019-21. PubMed ID: 6353135
[TBL] [Abstract][Full Text] [Related]
50. Regulation of mitochondrial glycerol-phosphate dehydrogenase by Ca2+ within electropermeabilized insulin-secreting cells (INS-1).
Rutter GA; Pralong WF; Wollheim CB
Biochim Biophys Acta; 1992 Dec; 1175(1):107-13. PubMed ID: 1482691
[TBL] [Abstract][Full Text] [Related]
51. In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243.
Kobayashi T; Nakanishi K; Nakase H; Kajio H; Okubo M; Murase T; Kosaka K
Diabetes; 1997 Oct; 46(10):1567-71. PubMed ID: 9313751
[TBL] [Abstract][Full Text] [Related]
52. [Insular modifications in glycerophosphate dehydrogenase in diabetes].
Malaisse WJ; Rasschaert J
Bull Mem Acad R Med Belg; 1991; 146(1-2):106-10; discussion 111-2. PubMed ID: 1933065
[TBL] [Abstract][Full Text] [Related]
53. Decreased levels of metabolic enzymes in pancreatic islets of patients with type 2 diabetes.
MacDonald MJ; Longacre MJ; Langberg EC; Tibell A; Kendrick MA; Fukao T; Ostenson CG
Diabetologia; 2009 Jun; 52(6):1087-91. PubMed ID: 19296078
[TBL] [Abstract][Full Text] [Related]
54. Mitochondrial glycerol-3-phosphate dehydrogenase. Cloning of an alternatively spliced human islet-cell cDNA, tissue distribution, physical mapping, and identification of a polymorphic genetic marker.
Ferrer J; Aoki M; Behn P; Nestorowicz A; Riggs A; Permutt MA
Diabetes; 1996 Feb; 45(2):262-6. PubMed ID: 8549872
[TBL] [Abstract][Full Text] [Related]
55. Enzymic and metabolic anomalies in islets of diabetic rats: relationship to B cell mass.
Giroix MH; Baetens D; Rasschaert J; Leclercq-Meyer V; Sener A; Portha B; Malaisse WJ
Endocrinology; 1992 May; 130(5):2634-40. PubMed ID: 1315252
[TBL] [Abstract][Full Text] [Related]
56. Oscillations in activities of enzymes in pancreatic islet subcellular fractions induced by physiological concentrations of effectors.
MacDonald MJ; Al-Masri H; Jumelle-Laclau M; Cruz MO
Diabetes; 1997 Dec; 46(12):1996-2001. PubMed ID: 9392486
[TBL] [Abstract][Full Text] [Related]
57. Detection of variants in the mitochondrial glycerophosphate dehydrogenase gene in Japanese NIDDM patients.
Takeuchi Y; Matsutani A; Oka Y
Diabetologia; 1997 Mar; 40(3):339-43. PubMed ID: 9084974
[TBL] [Abstract][Full Text] [Related]
58. Physiology and pathology of islet metabolism.
Malaisse WJ
Diabete Metab; 1994; 20(2):95-8. PubMed ID: 7805957
[TBL] [Abstract][Full Text] [Related]
59. Autoantibodies against mitochondrial glycerophosphate dehydrogenase in patients with IDDM.
Fabregat ME; Gasa R; Rodriguez C; Novials A; Gallart T; Malaisse WJ; Gomis R
Diabetes Res Clin Pract; 1997 Nov; 38(2):115-21. PubMed ID: 9483375
[TBL] [Abstract][Full Text] [Related]
60. The effect of glucose and calcium on Ca2+-adenosine triphosphatase in pancreatic islets isolated from a normal and a non-insulin-dependent diabetes mellitus rat model.
Levy J; Zhu Z; Dunbar JC
Metabolism; 1998 Feb; 47(2):185-9. PubMed ID: 9472968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
